TDM Equations
TDM Equations
TDM Equations
Useful equations
Intermittent intravenous C = [k0/(keV)](1 − e−ket′ ) C = [k0/(keV)](1 − e−ket′) [(1 − e−nkeτ)/(1 − e−keτ)] C = [k0/(keV)][(1 − e−ket′) / (1 − e−keτ)]
infusion
Symbol key: C is drug serum concentration at time = t, D is dose, V is volume of distribution, ke is the elimination rate constant, n is the number of administered doses,
τ is the dosage interval, k0 is the infusion rate, Cl is clearance, t′ is infusion time, N/A is not applicable.
40
TABLE 2-2 Single-Dose, Multiple-Dose, and Steady-State Pharmacokinetic Constant Computations Utilizing a One Compartment Model
ROUTE OF
ADMINISTRATION SINGLE DOSE MULTIPLE DOSE STEADY STATE
Intravenous bolus ke = − (ln C1 − ln C2) / (t1 − t2) ke = − (ln C1 − ln C2) / (t1 − t2) ke = − (ln C1 − ln C2) / (t1 − t2)
t1/2 = 0.693/ke t1/2 = 0.693/ke t1/2 = 0.693/ke
V = D/C0 V = D/(C0 − Cpredose) V = D/(C0 − Cpredose)
Cl = keV Cl = keV Cl = keV
Intermittent ke = − (ln C1 − ln C2) / (t1 − t2) ke = − (ln C1 − ln C2) / (t1 − t2) ke = − (ln C1 − ln C2) / (t1 − t2)
intravenous infusion t1/2 = 0.693/ke t1/2 = 0.693/ke t1/2 = 0.693/ke
V = [k0(1 − e−ket′)] / {ke[Cmax − (Cpredosee−ket′)]} V = [k0(1 − e−ket′)] / {ke[Cmax − (Cpredosee−ket′)]} V = [k0(1 − e−ket′)] / {ke[Cmax − (Cpredosee−ket′)]}
Cl = keV Cl = keV Cl = keV
Extravascular ke = − (ln C1 − ln C2) / (t1 − t2) ke = − (ln C1 − ln C2) / (t1 − t2) ke = − (ln C1 − ln C2) / (t1 − t2)
(postabsorption, t1/2 = 0.693/ke t1/2 = 0.693/ke t1/2 = 0.693/ke
postdistribution) V/F = D/C0 V/F = D/(C0 − Cpredose) V/F = D/(C0 − Cpredose)
Cl/F = ke(V/F) Cl/F = ke(V/F) Cl/F = ke(V/F)
Symbol key: C1 is drug serum concentration at time = t1, C2 is drug serum concentration at time = t2, ke is the elimination rate constant, t1/2 is the half-life, V is the volume
of distribution, k0 is the continuous infusion rate, t′ is the infusion time, V/F is the hybrid constant volume of distribution/bioavailability fraction, D is dose, C0 is the
concentration at time = 0, Cl is drug clearance, Cl/F is the hybrid constant clearance/bioavailability fraction, Cpredose is the predose concentration, Css is the steady-state
concentration, N/A is not applicable.